• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS, INC. EVERSENSE CGM; CONTINUOUS GLUCOSE MONITOR, IMPLANTED ADJUCTIVE USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS, INC. EVERSENSE CGM; CONTINUOUS GLUCOSE MONITOR, IMPLANTED ADJUCTIVE USE Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Needle Stick/Puncture (2462)
Event Date 02/28/2020
Event Type  Injury  
Event Description
I passed out when the glucose reading was 65 on my eversense cgm.I am experiencing deviations of 50-80 points between fingerstick and cgm reading.The company is refusing to replace the product.Fda safety report id# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE CGM
Type of Device
CONTINUOUS GLUCOSE MONITOR, IMPLANTED ADJUCTIVE USE
Manufacturer (Section D)
SENSEONICS, INC.
MDR Report Key9818406
MDR Text Key183343110
Report NumberMW5093671
Device Sequence Number1
Product Code QCD
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 03/08/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received03/10/2020
Was Device Evaluated by Manufacturer? No Information
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age44 YR
Patient Weight79
-
-